Home > Qtrly Results > BLISS GVS PHARMA

BLISS GVS PHARMA
Quarterly Results Analysis [Jun2026]

BLISS GVS PHARMA is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for BLISS GVS PHARMA
Please provide your vote to see the results

BLISS GVS PHARMA Quarterly Results

Consolidated Jun2026
UnAudited
Mar2026
UnAudited
Dec2025
UnAudited
Sep2025
UnAudited
Jun2025
UnAudited
Mar2025
UnAudited
Dec2024
UnAudited
Sep2024
Audited
Revenues ₹286 Cr ₹257 Cr ₹218 Cr ₹244 Cr ₹207 Cr ₹198 Cr ₹210 Cr ₹218 Cr
Expenses ₹209 Cr ₹213 Cr ₹183 Cr ₹213 Cr ₹166 Cr ₹177 Cr ₹181 Cr ₹178 Cr
Operating Income ₹76 Cr ₹44 Cr ₹35 Cr ₹32 Cr ₹41 Cr ₹21 Cr ₹30 Cr ₹40 Cr
Other Income ₹10 Cr ₹11 Cr ₹18 Cr ₹20 Cr ₹35 Cr ₹12 Cr ₹15 Cr ₹7 Cr
Interest ₹1 Cr ₹2 Cr ₹1 Cr ₹3 Cr ₹5 Cr ₹2 Cr ₹1 Cr ₹4 Cr
Depreciation ₹10 Cr ₹9 Cr ₹8 Cr ₹8 Cr ₹8 Cr ₹8 Cr ₹8 Cr ₹7 Cr
Profit Before Tax ₹75 Cr ₹45 Cr ₹41 Cr ₹41 Cr ₹63 Cr ₹23 Cr ₹36 Cr ₹36 Cr
Profit After Tax ₹51 Cr ₹37 Cr ₹25 Cr ₹29 Cr ₹44 Cr ₹17 Cr ₹26 Cr ₹26 Cr
EPS ₹4.72 ₹3.36 ₹2.20 ₹2.58 ₹4.08 ₹1.47 ₹2.26 ₹2.31
Industry Peers & Returns1W1M1Y
BLISS GVS PHARMA 12.1% 25.8% 242.9%
SUN PHARMACEUTICAL INDUSTRIES 1% -2.7% 15.7%
DIVIS LABORATORIES 0.7% 17.1% 40.1%
TORRENT PHARMACEUTICALS -0.3% -3.7% 37.9%
CIPLA -0.3% 2.3% -8.1%
DR REDDYS LABORATORIES -1.4% 0.7% -6.2%
MANKIND PHARMA -1.2% -7.2% -3.5%
LUPIN -2.9% -8.5% 12.4%
ZYDUS LIFESCIENCES -1.1% 0.6% 12.1%

BLISS GVS PHARMA Quarterly Revenues

Revenues
Q-o-Q

11.12 %

Y-o-Y

37.65 %

Quarters Revenues % Change
Jun2026 ₹286 Cr
11.12
Mar2026 ₹257 Cr
17.75
Dec2025 ₹218 Cr
-10.70
Sep2025 ₹244 Cr
17.80
Jun2025 ₹207 Cr
4.79
Mar2025 ₹198 Cr
-5.91
Dec2024 ₹210 Cr
-3.34
Sep2024 ₹218 Cr -

BLISS GVS PHARMA Quarterly Operating Profit

Operating Profit
Q-o-Q

71.92 %

Y-o-Y

84.86 %

Quarters Operating Profit % Change
Jun2026 ₹76 Cr
71.92
Mar2026 ₹44 Cr
27.74
Dec2025 ₹35 Cr
9.54
Sep2025 ₹32 Cr
-23.16
Jun2025 ₹41 Cr
96.01
Mar2025 ₹21 Cr
-29.22
Dec2024 ₹30 Cr
-25.04
Sep2024 ₹40 Cr -
Operating Margins
Q-o-Q

54.71 %

Y-o-Y

34.29 %

Quarters Operating Margin% % Change
Jun2026 26.75%
54.71
Mar2026 17.29%
8.47
Dec2025 15.94%
22.71
Sep2025 12.99%
-34.79
Jun2025 19.92%
87.04
Mar2025 10.65%
-24.79
Dec2024 14.16%
-22.45
Sep2024 18.26% -

BLISS GVS PHARMA Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

38.85 %

Y-o-Y

15.81 %

Quarters Profit After Tax % Change
Jun2026 ₹51 Cr
38.85
Mar2026 ₹37 Cr
49.32
Dec2025 ₹25 Cr
-13.33
Sep2025 ₹29 Cr
-35.55
Jun2025 ₹44 Cr
166.40
Mar2025 ₹17 Cr
-35.46
Dec2024 ₹26 Cr
0.42
Sep2024 ₹26 Cr -
PAT Margins
Q-o-Q

24.93 %

Y-o-Y

-15.86 %

Quarters PAT Margin(%) % Change
Jun2026 17.99 %
24.93
Mar2026 14.4 %
26.87
Dec2025 11.35 %
-2.99
Sep2025 11.7 %
-45.28
Jun2025 21.38 %
154.22
Mar2025 8.41 %
-31.40
Dec2024 12.26 %
3.90
Sep2024 11.8 % -

BLISS GVS PHARMA Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

40.48 %

Y-o-Y

15.69 %

Quarters EPS % Change
Jun2026 ₹4.72
40.48
Mar2026 ₹3.36
52.73
Dec2025 ₹2.2
-14.73
Sep2025 ₹2.58
-36.76
Jun2025 ₹4.08
177.55
Mar2025 ₹1.47
-34.96
Dec2024 ₹2.26
-2.16
Sep2024 ₹2.31 -

You may also like the below Video Courses